首页 | 本学科首页   官方微博 | 高级检索  
检索        

4种头孢类抗生素治疗儿童支气管肺炎的成本-效果分析
引用本文:乔小云,孔戴艳,等.4种头孢类抗生素治疗儿童支气管肺炎的成本-效果分析[J].中国药房,2001,12(1):31-32.
作者姓名:乔小云  孔戴艳
摘    要:目的 :研究头孢唑啉、头孢三嗪、头孢噻肟和头孢呋辛治疗儿童支气管肺炎的成本 -效果。方法 :采用回顾性研究和成本 -效果分析法 ,计算儿童支气管肺炎患者的治疗成本 ,进行药物经济学评价。结果 :头孢唑啉、头孢三嗪、头孢呋辛、头孢噻肟治疗儿童支气管肺炎的成本分别为512 84、725 42、796 28、734 16元。成本 -效果比分别为93 68、475 83、517 30、412 28。结论 :与头孢三嗪、头孢呋辛和头孢噻肟相比 ,用头孢唑啉治疗儿童支气管肺炎最经济 ,但在评价某一药物治疗成本的同时 ,必须考虑药物的疗效和疗程

关 键 词:儿童支气管肺炎  药物经济学  成本-效果

Pharmacoeconomic Analysis of Treatment of Child Bronchopneumonia With Four Varieties of Cephalospo-rins
Abstract:OBJECTIVE:To carry out the cost-effectiveness analysis of treating child bronchopneumonia with cefazolin,cefatrizine,cefataxime and cefuroxime METHODS:Using retrospective study and cost-effectiveness analysis,the costs of tre_atment of children with bronchopneumonia were calculated and pharmacoeconomically evaluated RESULTS:The costs of cefazolin,cefatrizine,cefuroxime and cefataxime in treatment of child bronchopneumonia were RMB 512 84,725 42,796 28 and 734 16 yuan and the cost-effectiveness ratios were 93 68,475 83,517 30 and 412 28 respectively CONCLUSION:In comparison with cefatrizine,cefuroxime and cefataxime,cefazolin is the most inexpensive one However,in evaluating the therapeutic cost of a drug, we should consider its therapeutic efficacy and course
Keywords:child bronchopneumonia  pharmacoeconomics  cost-effectiveness
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号